MEDICAL ECONOMICS PODCASTS

podcast

A variety of Medical Economics Podcasts* are right here—at your fingertips!
Start listening today to expert insights that can help improve your patient and practice management.
  • To download and listen at your own convenience, right-click (or option-click) one of the links below and select “Save Target as . . . ”
  • To listen now without downloading, click one of the links below

We suggest turning off any pop-up blockers before accessing the podcast links below.

Patient education: challenges and solutions

Dr. Brain Primack, Associate Professor of Medicine and Pediatrics,

University of Pittsburgh School of Medicine

Get tips and suggestions on how to improve your patients’ health literacy—almost 50% of adults in the
United States do not understand basic health instructions! Dr. Primack will show you ways to clearly
and effectively present important health information to your patients.

Download  |  Add to iTunes®

Get your staff functioning well

Dr. Lynn Helmer, President, DRD Consulting Incorporated

Learn how effective teamwork, a keystone of successful practice management, can counteract the potential chaos caused by organizational concerns like scheduling, billing and staff communication.

Download  |  Add to iTunes®

How to choose the right EMR

Listen to an experienced medical office manager with information technology insight discuss how to choose the right EMR/EHR for you and your practice.

Download  |  Add to iTunes®

Eliminating waits and delays

Get practical advice from a healthcare consultant on managing patient overload during busy seasons, reworking your scheduling to help improve workflow and if open access is right for your practice.

Download  |  Add to iTunes®

How to communicate with patients to ensure patient satisfaction

Dr. Stephen Stralser, Global Entrepreneurship Center at Thunderbird School of Internal Management

Learn about the Patient Communication for Patient Satisfaction (PCPS) model of patient care. Dr. Stralser also shares the results of a 10-year longitudinal study on patient satisfaction to find out what patients really want when it comes to their healthcare.

Download  |  Add to iTunes®

Get your staff on board with EMR

Rosemarie Nelson, Medical Office Manager, Consultant

Gain valuable advice about how to help your office staff embrace new technologies. Learn how open communication and proper training can make a world of difference among your staff.

Download  |  Add to iTunes®

*The publishers of Medical Economics are solely responsible for the content of these podcasts.
iTunes® is a registered trademark of Apple Inc.

 
INDICATIONS
  • In adults (≥18 years of age), ACIPHEX® 20 mg is indicated for: treatment of daytime and nighttime heartburn and other symptoms associated with GERD; short-term, up to 4 weeks, treatment in the healing and symptomatic relief of duodenal ulcers; short-term, 4 to 8 weeks, treatment in the healing and symptomatic relief of erosive GERD; and maintenance of healing and reduction in relapse rates of heartburn symptoms in erosive GERD (controlled maintenance studies do not extend beyond 12 months)
  • In adolescent patients 12 years of age and above, ACIPHEX® 20 mg is indicated for: short-term, up to 8 weeks, treatment of daytime and nighttime heartburn and other symptoms associated with GERD
IMPORTANT SAFETY INFORMATION
Contraindications:
  • ACIPHEX® is contraindicated in patients with known hypersensitivity to rabeprazole, substituted benzimidazoles, or to any component of the formulation
Warnings and Precautions:
  • Symptomatic response to therapy does not preclude the presence of gastric malignancy
  • As with all PPIs, patients treated concomitantly with warfarin may need to be monitored for increases in INR and prothrombin time. Increases in INR and prothrombin time may lead to abnormal bleeding and even death
  • Long-term and multiple daily dose PPI therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist or spine
  • Hypomagnesemia has been reported rarely with prolonged treatment with PPIs. Serious adverse events include tetany, arrhythmias, and seizures. Consider monitoring magnesium levels in patients on prolonged PPI therapy or concomitant medications such as digoxin or medications that may cause hypomagnesemia (eg, diuretics)
Adverse Events:
  • In adolescents, the related reported adverse reactions that occurred in ≥2% of patients were headache and nausea. The adverse reactions reported without regard to relationship to ACIPHEX® that occurred in ≥2% of patients were headache, diarrhea, nausea, vomiting, and abdominal pain
  • In adults, clinical trials revealed the following adverse reactions appearing in ≥2% of ACIPHEX® patients and with a frequency greater than placebo: pain, pharyngitis, flatulence, infection, and constipation
Drug Interactions:
  • ACIPHEX® inhibits gastric acid secretion and may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (eg, ketoconazole, iron salts and digoxin)
  • ACIPHEX® may reduce the plasma levels of atazanavir
  • Rabeprazole has been shown to inhibit cyclosporine metabolism in vitro

For more information about ACIPHEX®, see full Prescribing Information.

Click here to view full Prescribing Information for ACIPHEX®.

 
Thank you for visiting aciphex360.com.
By clicking "Continue" you will be taken to: